Sunday, November 19, 2017 8:24:09 PM
being $0.0001 with no bid whatsoever, with zero to limited liquidity in the trading of the
Company’s stock; a situation that has prevailed for over a year. This abnormally low stock price,
no liquidity and no bid has resulted in the Company’s complete inability to raise necessary
financing or consummate any transactions whatsoever.
On January 26, 2016, the Board and holders of a majority of the voting power of the
Company approved a further reverse split of the Company’s Common Stock in the ratio
of 3 to 1. This means that after the reverse stock split has taken effect, you will own one
share of C4 Odyssey, Inc. (Formerly GNCC Capital, Inc.) Common Stock for each 6,000
shares of GNCC Common Stock that you currently own.
This was approved and filed by the Secretary of State in Wyoming on February 3, 2016.
Following the reverse stock split, we will have approximately 4,456,850 shares of
Common Stock issued and outstanding. As at February 3, 2016, the Company had
26,741,103,470 shares of outstanding Common Stock.
As at February 3, 2016, there are 14,348,166,231 shares of Common Stock on deposit at
the DTCC. Following the reverse stock split, we will have approximately 2,391,361
shares of Common Stock on deposit at the DTCC.
The Company has requested that two additional stockholders representing 2,101,251,086
shares of the Company’s Common Stock on deposit at the DTCC, request that their
shares of Common Stock be placed in certificate form. Should they comply with the
Company’s request, this will reduce the shares of Common Stock on deposit at the DTCC
to 11,867,897,635; and following the reverse stock split, we would then have
approximately 1,977,982 shares of Common Stock on deposit at the DTCC. There are no
assurances that either of these stockholders will comply with the Company’s request.
As at February 3, 2016, the Company has 12,392,937,239 shares of restricted shares of
Common Stock issued and outstanding. Following the reverse stock split, the Company
will have approximately 2,065,489 shares of restricted shares of Common Stock issued
and outstanding.
2. CHANGE IN COMPANY NAME
On November 9, 2015, the Board and holders of a majority of the voting power of the
Company approved a change of the Company’s name to “C4 Odyssey, Inc.”.
As a result, we filed an amendment to our Articles of Incorporation with the State of
Wyoming to effectuate this reverse stock split and change in name.
This was approved and filed by the Secretary of State in Wyoming on November 19,
2015.
3. CHANGE IN CUSIP NUMBER
Effective November 24, 2015, the Company was allocated a new CUSIP as follows:-
ISSUER: C4 ODYSSEY, Inc.
CUSIP NUMBER: 15723P 108
ISIN NUMBER: US15723P1084
ISSUE DESCRIPTION: COMMON STOCK
INITIAL REVERSE SPLIT OF THE COMPANY’S COMMON STOCK
On November 9, 2015, the Board and holders of a majority of the voting power of the Company
approved a reverse split of the Company’s Common Stock in the ratio of 2,000 to 1. This means
that after the reverse stock split has taken effect, you will own one share of GNCC Common
Stock for each 2,000 shares of GNCC Common Stock that you currently own.
This was approved and filed by the Secretary of State in Wyoming on November 19, 2015.
RATIONALE FOR THE FURTHER REVERSE SPLIT OF THE COMPANY’S
COMMON STOCK
The Company’s common stock has been and is currently trading at a highly depressed value,
being $0.0001 with no bid whatsoever, with zero to limited liquidity in the trading of the
Company’s stock; a situation that has prevailed for over a year. This abnormally low stock price,
no liquidity and no bid has resulted in the Company’s complete inability to raise necessary
financing or consummate any transactions whatsoever.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM